[DarioHealth in Yahoo Finance] Dario Health to Host Key Opinion Leader Call on Digital Therapeutics for the Management of Diabetes and Other Chronic Conditions

OurCrowd

Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that it will host a key opinion leader (KOL) call on digital therapeutics for the management of diabetes and other chronic conditions on Tuesday, June 23, 2020 at 10:30 a.m. The post [DarioHealth in Yahoo Finance] Dario Health to Host Key Opinion Leader Call on Digital Therapeutics for the Management of Diabetes and Other Chronic Conditions appeared first on OurCrowd.

[DarioHealth in PR Newswire] DarioHealth CEO Erez Raphael Presents to Digital Therapeutics Leaders at DTx East 2019

OurCrowd

NASDAQ: DRIO) (“DarioHealth” or “Dario”), a leading, global digital therapeutics company, today announced that Erez Raphael, DarioHealth’s Chief Executive Officer, will be a speaker at the second annual DTx East 2019 conference taking place at Harvard Medical School in Boston, MA from September 24-26, 2019. DarioHealth Corp.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

[DarioHealth in Yahoo Finance] DarioHealth Announces Poster Presentation at the Virtual Association of Diabetes Care and Education Specialists 2020 Annual Conference

OurCrowd

Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that an emerging science industry poster has been accepted for presentation at the virtual Association of Diabetes Care and Education Specialists (ADCES) 2020 Annual Conference, Read more here.

[DarioHealth in PR Newswire] DarioHealth® Clinical Study Data Shows the Dario Membership Program Assists Diabetes Patients in Achieving Pre-Diabetic Blood-Glucose Levels and Consistent In-Range Measurements

OurCrowd

NASDAQ: DRIO) (“DarioHealth” or “Dario”), a leading global, digital therapeutics company, presented new clinical data yesterday at the American Association of Diabetes Educators (“AADE”) conference in Houston, Texas, which showed remarkable improvements in average blood-glucose levels and in-range measurements in patients with diabetes using Dario’s digital therapeutics platform and dedicated one-on-one personal health coaching.

[Medisafe in New Kerala] Medisafe and Everyday Health Team up to Provide Patients with Coronavirus Updates

OurCrowd

Medisafe, a leading digital therapeutics company providing medication management solutions for patients across the healthcare continuum, announced a partnership with the Everyday Health Group, a recognized leader in patient and provider education and services.

[Medisafe in Market Insider] Medisafe and Everyday Health Team up to Provide Patients with Coronavirus Updates

OurCrowd

BOSTON, May 13, 2020 /PRNewswire/ — Medisafe, a leading digital therapeutics company providing medication management solutions for patients across the healthcare continuum, today announced a partnership with the Everyday Health Group, a recognized leader in patient and provider education and services.

[Medisafe in PR Newswire] Medisafe Adds Pharmacy Integration to Its Platform, Now Delivers Medications to Patients

OurCrowd

Medisafe, a leading evidenced-based digital therapeutics company collaborating with healthcare organizations to provide medication management solutions for patients, today announced their new capabilities to integrate pharmacy services providing the last mile of services and completing a holistic patient journey management solution for medication management.

[Medisafe in McNight’s] Medisafe Maestro aims to bring precision to medication adherence

OurCrowd

Digital therapeutics companion platform Medisafe has deployed its new Maestro platform, which aims to orchestrate medication adherence journeys with precision and speed and create personalized patient support resources.

[DarioHealth in Yahoo Finance] DarioHealth Self-test Blood Glucose Meters Can Now Be Utilized Within Hospitals During the COVID-19 Pandemic Per Recently Issued Emergency FDA Guidelines

OurCrowd

Nasdaq: DRIO), a global digital therapeutics (DTx) innovator, announced today that in an effort to reduce contact between healthcare providers and patients in hospital settings, limit COVID-19 exposure, and preserve personal protective equipment (PPE), the U.S. NEW YORK, May 6, 2020 /PRNewswire/ — DarioHealth Corp.

[DarioHealth in Yahoo Finance] DarioHealth Expands Offering to Include Behavioral Health

OurCrowd

Nasdaq: DRIO), a leading global digital therapeutics (DTx) innovator, announced today that it has expanded its offering on its chronic care platform application to include behavioral health coaching for stress, anxiety and loneliness, conditions which have recently escalated due to COVID-19 social distancing restrictions including “shelter-in-place” and “stay-at-home” orders. NEW YORK, May 4, 2020 /PRNewswire/ — DarioHealth Corp.

[DarioHealth in Yahoo Finance] DarioHealth Digital Diabetes Management System is Now Available at Albertsons

OurCrowd

NASDAQ: DRIO), a pioneer in the global digital therapeutics market, announced today the launch of its digital therapeutics solution for managing chronic diseases such as diabetes and hypertension on Albertsons Marketplace. The post [DarioHealth in Yahoo Finance] DarioHealth Digital Diabetes Management System is Now Available at Albertsons appeared first on OurCrowd. DarioHealth Corp.

[DarioHealth in FDA Health News] DARIOHEALTH: Self-test Blood Glucose Meters Can Now Be Utilized Within Hospitals During the COVID-19 Pandemic Per Recently Issued Emergency FDA Guidelines

OurCrowd

Nasdaq: DRIO), a global digital therapeutics (DTx) innovator, announced today that in an effort to reduce contact between healthcare providers and patients in hospital settings, limit COVID-19 exposure, and preserve personal protective equipment (PPE), the U.S. DarioHealth Corp.

MedRhythms Uses the Universal Language of Music to Bring Hope, Healing to Mobility Impaired Patients

Angel Capital Association

MedRhythms, a Portland, Maine-based digital therapeutics company, is building direct stimulation, prescription therapeutics that use sensors, music, and software to improve loss of mobility caused by neurologic injuries and diseases. The digital therapeutic platform is designed to digitize an evidence-based intervention known as Rhythmic Auditory Stimulation ( see MedRhythms Scientific Approach Summary ).

[DarioHealth in Yahoo Finance] DarioHealth Appoints Eric Milledge as Chairman of its Newly Established Scientific Advisory Board

OurCrowd

Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announces that Eric Milledge has joined DarioHealth as Chairman of the company’s newly-established Scientific Advisory Board (SAB). DarioHealth Corp.

[Medisafe in PR Newswire] Medisafe Brings Precision and Speed to Patient Journeys with new Medisafe Maestro technology

OurCrowd

Medisafe, a leading digital therapeutics companion platform, today announced the immediate deployment of its new Medisafe Maestro platform.

[DarioHealth in StreetInsider.com] DarioHealth Appoints Eric Milledge as Chairman of its Newly Established Scientific Advisory Board

OurCrowd

a multi-billion-dollar diabetes franchise previously owned by Johnson & Johnson (JNJ) Scientific Advisory Board will help develop and execute the Company’s strategic roadmap for refining, improving and expanding its digital therapeutics platform.

[Medisafe in HIT Consultant] Medisafe Launches New Platform for Medication Management to Improve Patient Journey

OurCrowd

Medisafe, a Boston, MA-based digital therapeutics companion platform, announced the immediate deployment of its new Medisafe Maestro platform.

[DarioHealth in PR Newswire] DarioHealth® Clinical Study Data Highlights the Material Benefit Digital Interventions Have on Glycemic Control in Users with Diabetes

OurCrowd

Nasdaq: DRIO) (“DarioHealth” or “Dario”), a leading global, digital therapeutics company, presented new clinical data yesterday at the 19th Annual Diabetes Technology Meeting (“DTM”) conference in Bethesda, Maryland, which showed remarkable improvements in average blood glucose levels (BGavg) and in-range measurements in patients with diabetes using Dario’s digital therapeutics platform and dedicated one-on-one personal health coaching.

[DarioHealth in Globes] DarioHealth raises $21.3m in private placement

OurCrowd

The Israeli company plans to use some of the funding to increase the breadth of chronic conditions addressed by DarioHealth’s digital therapeutics platform. Read more here. The post [DarioHealth in Globes] DarioHealth raises $21.3m in private placement appeared first on OurCrowd. News Center ourcrowd fund OurCrowd Qure portfolio news

[Medisafe in Yahoo Finance] Medisafe Stimulates Patient Connectivity to Combat COVID-19 Social Distancing Challenges

OurCrowd

BOSTON, April 6, 2020 /PRNewswire/ — Medisafe, a leading digital therapeutics companion company providing medication management solutions for patients across the healthcare continuum, today announced the immediate deployment of on-demand and ongoing support for patients worldwide facing new challenges as a result of COVID-19.

[DarioHealth in PR Newswire] DarioHealth Clinical Study Data Highlights the Material Benefit Digital Interventions Have on Glycemic Control in Users with Diabetes

OurCrowd

DarioHealth’s digital therapeutics platform delivers personalized, evidence-based interventions to users that are driven by precision data analytics, high quality software and one-on-one coaching, which are all available through Dario’s suite of membership plans. The post [DarioHealth in PR Newswire] DarioHealth Clinical Study Data Highlights the Material Benefit Digital Interventions Have on Glycemic Control in Users with Diabetes appeared first on OurCrowd.

[DarioHealth in BioSpace] DarioHealth Launches New Blood Pressure Monitoring System

OurCrowd

DarioHealth, a leading global, digital therapeutics company, announced today the addition of a new digital monitoring solution on its Dario app platform that will allow patients to monitor their blood pressure throughout the day, in addition to their blood glucose levels.

[DarioHealth in PR Newswire] DarioHealth Launches New Blood Pressure Monitoring System

OurCrowd

Nasdaq: DRIO), (“DarioHealth” or “Dario”), a leading global, digital therapeutics company, announced today the addition of a new digital monitoring solution on its Dario app platform that will allow patients to monitor their blood pressure throughout the day, in addition to their blood glucose levels. DarioHealth Corp.

[DarioHealth in Yahoo Finance] DarioHealth Awarded U.S. Patent for Optical Transmission of Data Between a Sensor and Smart Device

OurCrowd

DarioHealth Corp. (“DarioHealth” or “Dario”) (DRIO), a leading, global digital therapeutics company, today announced that it has received a notice of allowance from the U.S. Patent and Trademark Office titled “Systems and Methods for Enabling Optical Transmission of Data Between a Sensor and a Smart Device.” ” Read more here. The post [DarioHealth in Yahoo Finance] DarioHealth Awarded U.S.

[DarioHealth in Yahoo Finance] DarioHealth Awarded U.S. Patent for Optical Transmission of Data Between a Sensor and Smart Device

OurCrowd

DarioHealth Corp. (“DarioHealth” or “Dario”) (DRIO), a leading, global digital therapeutics company, today announced that it has received a notice of allowance from the U.S. Patent and Trademark Office titled “Systems and Methods for Enabling Optical Transmission of Data Between a Sensor and a Smart Device.” ” Read more here. The post [DarioHealth in Yahoo Finance] DarioHealth Awarded U.S.

[DarioHealth in Yahoo Finance] DarioHealth Announces Alliance with DigitalHealth.London As Part of the UK Israel Dangoor Health Initiative

OurCrowd

DarioHealth Corp. (“DarioHealth” or “Dario”) (DRIO), a leading, global digital therapeutics company, today announced an alliance with DigitalHealth.London (“DH.L”) ”) as part of its UK Israel Dangoor Health Initiative (the “Initiative”), which aims to partner leading Israeli digital health companies with the UK National Health Service (NHS) to benefit patients.